Condition
Squamous Cell Carcinomas
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (2)
Trial Status
Completed2
Active Not Recruiting1
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01706939Phase 3Active Not RecruitingPrimary
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
NCT05482880Completed
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
NCT04266327Not ApplicableUnknown
RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes
NCT04142489Not ApplicableCompletedPrimary
In Vivo Damage Induced bu UV in the Epidermis of the Scalp
NCT01532453Phase 3Terminated
Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients
Showing all 5 trials